Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Grandjean, J G"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1dee9921d2b4711b8d074e55c31c9825
http://hdl.handle.net/11568/84514
http://hdl.handle.net/11568/84514
Autor:
Brundel, B J, Van Gelder, I C, Henning, R H, Tuinenburg, A E, Wietses, M, Grandjean, J G, Wilde, A A, Van Gilst, W H, Crijns, H J
Publikováno v:
Brundel, B J, Van Gelder, I C, Henning, R H, Tuinenburg, A E, Wietses, M, Grandjean, J G, Wilde, A A, Van Gilst, W H & Crijns, H J 2001, ' Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation : differential regulation of protein and mRNA levels for K+ channels ', Journal of the American College of Cardiology, vol. 37, no. 3, pp. 926-32 .
OBJECTIVES: Our purpose was to determine whether patients with persistent atrial fibrillation (AF) and patients with paroxysmal AF show alterations in potassium channel expression.BACKGROUND: Persistent AF is associated with a sustained shortening of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10172::60ea1f9a0d71656267ab4b4f25153f18
https://research.vumc.nl/en/publications/3768f6fd-6876-4e54-8f5d-fab19fce6a03
https://research.vumc.nl/en/publications/3768f6fd-6876-4e54-8f5d-fab19fce6a03
Autor:
Oosterga, M., Voors, A. A., Pinto, Y. M., Buikema, H., Grandjean, J. G., Kingma, J. H., Crijns, H. J., van Gilst, W. H.
Publikováno v:
American journal of cardiology, 87(5), 542-546. Elsevier Inc.
The QUO VADIS study was designed to explore whether 1 year of angiotensin-converting enzyme inhibition with quinapril (40 mg/day) would decrease ischemia in patients who underwent coronary artery bypass grafting (CABG). Patients (n = 149) scheduled f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::89e350d5d513418a692037787a885911
https://pure.amc.nl/en/publications/effects-of-quinapril-on-clinical-outcome-after-coronary-artery-bypass-grafting-the-quo-vadis-study-quinapril-on-vascular-ace-and-determinants-of-ischemia(19034396-827a-4c72-9408-9377f98d0a5f).html
https://pure.amc.nl/en/publications/effects-of-quinapril-on-clinical-outcome-after-coronary-artery-bypass-grafting-the-quo-vadis-study-quinapril-on-vascular-ace-and-determinants-of-ischemia(19034396-827a-4c72-9408-9377f98d0a5f).html
Autor:
Gelder, I. C., Brundel, B. J. J. M., Henning, R. H., Tuinenburg, A. E., Tieleman, R. G., Deelman, L., Grandjean, J. G., Kam, P. J., Wiek van Gilst, Crijns, H. J. G. M.
Publikováno v:
Van Gelder, IC, Brundel, BJJM, Henning, RH, Tuinenburg, AE, Tieleman, RG, Deelman, L, Grandjean, JG, De Kam, PJ, Van Gilst, WH & Crijns, HJGM 1999, ' Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation ', JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, vol. 10, no. 4, pp. 552-560 .
Journal of Cardiovascular Electrophysiology, 10(4), 552-560. Wiley
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 10(4), 552-560. Wiley-Blackwell Publishing Ltd
Scopus-Elsevier
Journal of Cardiovascular Electrophysiology, 10(4), 552-560. Wiley
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 10(4), 552-560. Wiley-Blackwell Publishing Ltd
Scopus-Elsevier
Gene Expression in Human Atrial Fibrillation, Introduction: Atrial fibrillation (AF) leads to a loss of atrial contraction within hours to days. During persistence of AF, cellular dedifferentiation and hypertrophy occur, eventually resulting in degen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::07d11903b91abe18ab99066e4bdb05fe
https://research.vumc.nl/en/publications/6e69f5d8-7235-4afb-a63f-231c8ecfe0aa
https://research.vumc.nl/en/publications/6e69f5d8-7235-4afb-a63f-231c8ecfe0aa
Autor:
Voors, A. A., Pinto, Y. M., Buikema, H., Urata, H., Oosterga, M., Rooks, G., Grandjean, J. G., Ganten, D., van Gilst, W. H.
Publikováno v:
British Journal of Pharmacology, 125(5), 1028-1032. Wiley-Blackwell
British journal of pharmacology, 125(5), 1028-1032. Wiley-Blackwell
British journal of pharmacology, 125(5), 1028-1032. Wiley-Blackwell
1. Angiotensin converting enzyme (ACE) is thought to be the main enzyme to convert antiotensin I to the vasoactive angiotensin II. Recently, in the human heart, it was found that the majority of angiotensin II formation was due to another enzyme, ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e6b010ad8e98f06da6766c95afb4fb9a
https://research.rug.nl/en/publications/a46db435-82bf-4cfb-be49-5a07c0da56ef
https://research.rug.nl/en/publications/a46db435-82bf-4cfb-be49-5a07c0da56ef
Autor:
Brundel, B J, Van Gelder, I C, Henning, R H, Tieleman, R G, Tuinenburg, A E, Wietses, M, Grandjean, J G, Van Gilst, W H, Crijns, H J
Publikováno v:
Circulation; 2001 Feb 6, Vol. 103 Issue 5, p684-690, 7p
Publikováno v:
European Heart Journal; 1996, Vol. 17 Issue 5, p787-794, 8p